Winterville, GA, United States of America

Scott Alan Brown

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Alan Brown. Retrieved from https://idiyas.com/inventor/scott-alan-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Alan Brown: Patent Activity in Veterinary Hypertension Treatment

Introduction

Scott Alan Brown is an inventor associated with Winterville, Georgia, United States. His patent work concerns a veterinary treatment approach involving telmisartan for hypertension in dogs.

Latest Patents

The provided information identifies one patent associated with Brown: “Telmisartan for the Treatment of Hypertension in Dogs.” The invention describes using telmisartan, or a pharmaceutically acceptable salt, as a medication for canine hypertension. It specifies that the therapeutically effective daily dosage may vary over the course of treatment. Brown is credited with 1 patent.

Career Highlights

Brown’s listed patent activity focuses on a veterinary pharmaceutical application. The invention addresses treatment dosing over time for dogs with hypertension.

Collaborations

The provided information lists Kate Elizabeth Creevy and Anne M. Traas as Brown’s coworkers. Their names are associated with his professional context, though specific roles in the patent are not stated.

Conclusion

Scott Alan Brown’s identified patent work centers on a variable daily dosing approach using telmisartan to treat hypertension in dogs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…